TARGET GPS

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 17 Sept 2024

Owner Info

Superluminal Medicines, Inc.

200 Berkeley Street, 18th Floor

Boston MA 02116, UNITED STATES OF AMERICA

Serial Number

2447276 filed on 5 Apr 2024

Correspondent

Gregory B. Coy Taft Stettinius & Hollister, LLP

One Indiana Square, Suite 3500,

Indianapolis IN 46204,

UNITED STATES OF AMERICA

TARGET GPS

Classification Information

2447276

5 Apr 2024

5 Apr 2034

WORD

6 Oct 2023

Status Date	Action Taken
17^th Sept 2024	Customer Amendment Made correspondence sent
17^th Sept 2024	Amendment to Address for Service Requested
20^th Aug 2024	International Registration in Australia Protected After Adverse (No amendments) correspondence sent
19^th Aug 2024	IP Right Registration Published
19^th Aug 2024	Status change to Registered/Protected
12^th Jun 2024	Application Accepted correspondence sent
11^th Jun 2024	IP Right has been Examined
11^th Jun 2024	IP Right Acceptance Published
11^th Jun 2024	Status change to Accepted
8^th May 2024	Adverse Report (Examination) correspondence sent